In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead explores the remarkable journey of AstraZeneca, from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decline, and ultimately its reinvention as a science-driven leader in oncology, cardiometabolic health, and global public health.
Discover how bold leadership, high-risk bets, and groundbreaking discoveries like Tagrisso, Enhertu, and Farxiga transformed AstraZeneca into one of today’s most innovative pharmaceutical giants.
Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!
https://linktr.ee/maneadkhin
#AstraZeneca #BiotechUnleashed #PetriDishPerspectives #BiotechPodcast #PharmaInnovation #Oncology #CardiometabolicHealth #PrecisionMedicine #DrugDiscovery #HealthcareLeadership
© 2025 Petri Dish Perspectives LLC. All rights reserved.